Abstract:Objective: This study explored the value of circulating tumor cells (CTC) detected by chromosome 8 centromere probe in diagnosis of non-small cell lung cancer (NSCLC) as well as correlation between CTC counts and clinical pathological characteristics. Methods: We collected 136 patients with newly diagnosed NSCLC (101 males and 35 females, age ranged from 34 to 79 years), 149 patients with non-malignant pulmonary diseases (103 males and 46 females, age ranged from 24 to 80 years) and 32 healthy volunteers (5 males and 27 females, age ranged from 24 to 42 years). Detection was performed using an epithelial cell adhesion molecule-independent strategy that combined immunocytochemistry staining (ICC) of CD(45) and fluorescence in situ hybridization detection (FISH) with chromosome 8 centromere probe (CEP8). CTC was defined as 4',6-diamidino-2-phenylindole (DAPI) positive, CD(45) negative and CEP8 more than 2 positive points. Quantitative data were reported as x±s and Mann Whitney test was used to compare them. Measurement data were analyzed as contingency tables and Pearson chi-squared test was used. P values of less than 0.05 were considered statistically significant. Results: CTCs were detected in 114 patients (83.8%) with NSCLC, 35 patients (23.5%) with non-malignant pulmonary diseases (P<0.000 1) and 5 volunteers (15.6%). CTC counts in NSCLC patients were (5.98±0.64) per 3.2 ml and (0.60±0.13) per 3.2 ml (P<0.000 1). A receiver operating characteristic curve (ROC) analysis showed similar capability of CTC count, with CEA, in discriminating NSCLC and non-malignant diseases with an area under ROC curve of 0.854 (95% confidence interval: 0.808-0.900, P<0.001). Cutoff of 2 circulating tumor cells per 3.2 ml peripheral blood gave the highest Youden Index of 0.614 in diagnosis of NSCLC with sensitivity of 72.1% (98/136) and specificity of 89.3% (133/149). When patients with CTC≥2/3.2 ml peripheral blood or serum CEA≥5 ng/ml were considered as having NSCLC, sensitivity and specificity of this combined test were 87.5% (119/136) and 85.9% (128/149), with a higher Youden Index of 0.734. No correlation was observed between positive rate of CTC (rate of patients with CTC≥2/3.2 ml peripheral blood) and age, gender, smoking status, pathologic types, and clinical stages. Conclusions: CTC counts detected by CD(45)-FISH is higher in NSCLC patients than in non-malignant disease patients. CTC≥2/3.2 ml peripheral blood is valuable in discriminating NSCLC from nonmalignant diseases, which can be more accurate when combined with CEA.

[Application of Combined Telomerase Activity Analysis and Immunocytochemistry in Cytopathologic Diagnosis].

Study of Telomerase Activity in Pleural Lavage Fluid Specimens in Patients with Non-Small-cell Lung Cancer and Its Clinical Significance

The Detectin of Telomerase Activity in Non-Small Cell Lung Cancer

The study of pleural lavage cytology for lung cancer

Telomerase Activity of Fibrobronchoscopic Brushing Cells in Non-Small Cell Lung Cancer

Application value of combined detection of exfoliative cytology,DNA heteroploid analysis and serum tumor marker in malignant pleural/ascitic fluid

Detection of Telomerase Activity in Pleural Effusion Cells from Patients with Malignant Neoplasm

Clinical Significance of CYFRA21-1, Scc-Ag and Telomerase Activity in Serum and Pleural Effusion of Patients with Squamous-Cell Lung Cancer.

Qualitative and quantitative assays for telomerase activity in specimens of ascites/pleural effusion cells

Blood Telomerase Activity and Its Correlativity with Non-Small Cell Lung Carcinoma

Celluar DNA Quantitative Analysis in Cytology for Clincal Application in Diagnosis

[The Value of Circulating Tumor Cells Detected by Chromosome Centromere Probe Identification in Diagnosis of Non-Small Cell Lung Cancer].

Detection of telomerase activity in bronchoscopic brushing cells of lung cancer patients

[Significance of Telomerase Activity Detection by Fine-Needle Aspiration in Patients with Breast Cancer].

Values of immunocytochemical and quantitative morphometric analyses in cytological differential diagnosis of pleural and peritoneal effusion

Study on Telomerase Activity in Exfoliated Cells from Humoral Specimens and its Significance

[Fluorescence in Situ Hybridization Combined with Cytomorphology for the Detection of Lung Cancer in Bronchial Brushing Specimens].

Application of Next Generation Sequencing in Pleural Effusion Molecular Profiling Using Oncomine™ Lung Cell-Free Total Nucleic Acid Research Assay.

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Immunohistochemical detection and molecular pathological examination of 142 cases of malignant pleural effusion

[Clinical Implications of Telomerase Activity in Breast Cancer Fine-Needle Aspirates].